Trial · NCT00867048
Results by group28
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 28
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Composite Endpoint of AIDS, Serious Non-AIDS Diagnoses, and All-cause Mortality | Early ART | 133 | Participants | ||
| Composite Endpoint of AIDS, Serious Non-AIDS Diagnoses, and All-cause Mortality | Deferred ART | 215 | Participants | ||
| AIDs or AIDs Related Death | Early ART | 31 | Participants | ||
| AIDs or AIDs Related Death | Deferred ART | 83 | Participants | ||
| Specific Non-AIDS Diagnoses | Early ART | 107 | Participants | ||
| Specific Non-AIDS Diagnoses | Deferred ART | 137 | Participants | ||
| Death, All-cause Mortality | Early ART | 66 | Participants | ||
| Death, All-cause Mortality | Deferred ART | 85 | Participants | ||
| Quality of Life- Mean Change From Baseline in a Visual Analog Scale (VAS) for Perceived Current Health | Early ART | 1.8 | Standard Deviation 8.6 | units on a scale | |
| Quality of Life- Mean Change From Baseline in a Visual Analog Scale (VAS) for Perceived Current Health | Deferred ART | 0.22 | Standard Deviation 8.7 | units on a scale | |
| Transmission Risk Behavior Outcome 1 | Early ART | 156 | Participants | ||
| Transmission Risk Behavior Outcome 1 | Deferred ART | 155 | Participants | ||
| Change in Neurocognitive Function (in a Subset of Participants) | Early ART | 0.19 | 95% Confidence Interval 0.16 to 0.23 | units on a scale | |
| Change in Neurocognitive Function (in a Subset of Participants) | Deferred ART | 0.21 | 95% Confidence Interval 0.18 to 0.25 | units on a scale | |
| Large Artery Elasticity (in a Subset of Participants) | Early ART | 0.27 | Full Range 0.02 to 0.53 | mL/mmHg x 10 | |
| Large Artery Elasticity (in a Subset of Participants) | Deferred ART | 0.8 | Full Range 0.52 to 1.07 | mL/mmHg x 10 | |
| Rate of Lung Function Decline (in a Subset of Participants) Among | Early ART | -36.6 | 95% Confidence Interval -51 to -22.3 | mL/yr | |
| Rate of Lung Function Decline (in a Subset of Participants) Among | Deferred ART | -38.8 | 95% Confidence Interval -52.8 to -24.8 | mL/yr | |
| Changes in Bone Mineral Density (in a Subset of Participants) Measure 1 | Early ART | -1.8 | 95% Confidence Interval -2.3 to -1.4 | percent | |
| Changes in Bone Mineral Density (in a Subset of Participants) Measure 1 | Deferred ART | -0.9 | 95% Confidence Interval -1.3 to -0.4 | percent |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00867048/results